APA (7th ed.) Citation

AS, M., VO, B., AC, D., MD, A., ALF, L., I, S., . . . LMB, S. (2021). Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients - Brief Research Report. Frontiers in cellular neuroscience, 15, 705618. https://doi.org/10.3389/fncel.2021.705618

Chicago Style (17th ed.) Citation

AS, Moraes, et al. "Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients - Brief Research Report." Frontiers in Cellular Neuroscience 15 (2021): 705618. https://doi.org/10.3389/fncel.2021.705618.

MLA (9th ed.) Citation

AS, Moraes, et al. "Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients - Brief Research Report." Frontiers in Cellular Neuroscience, vol. 15, 2021, p. 705618, https://doi.org/10.3389/fncel.2021.705618.